The presence of mercury in dental amalgams, or fillings, is relatively common knowledge; however, whether its presence affects the neurological system is a debate that has been ongoing for 150 years.
University of Iowa researchers investigating the basic biology of cell signaling have made a discovery that may have therapeutic implications for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
University of Iowa researchers have discovered a gene that plays a linchpin role in the ability of breast cancer cells to respond to estrogen. The finding may lead to improved therapies for hormone-responsive breast cancers, and may explain differences in the effectiveness of current treatments.
Patients with high blood pressure respond very differently to anti-hypertensive medication, making treatment selection tricky for physicians. But new research published in the online open access journal, BMC Medical Genetics, pinpoints a number of gene-drug interactions that could allow medication to be tailored to individual patients based on their genetics.
Dr. Bill Clemmer, a missionary based in the Democratic Republic of the Congo, is working with international agencies in an effort to confront an outbreak of the Ebola virus in that country.
Researchers at Deakin University have found that diesel exhaust is far more damaging to our health than exhaust from biodiesel, the plant-based fuel.
UCSF scientists are reporting what they say is a significant improvement in the technique for genetically reprogramming mouse cells to their embryonic state, a process that transforms the cells, in essence, into embryonic stem cells.
A biochemistry research team led by Dr. Andrew H.-J. Wang and Dr. Ting-Fang Wang at the Institute of Biological Chemistry, Academia Sinica(IBCAS), has discovered that the RecA family recombinases function as a new type of rotary motor proteins to repair DNA damages.
The Society for Cardiovascular Angiography and Interventions and the American College of Cardiology announced today that they will hold a unified interventional cardiology meeting in Chicago, March 29-April 1, 2008. The meeting will be known as “The SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit.” It will be held concomitantly with the ACC Annual Scientific Session.
A tailored virus destroys brain tumor stem cells that resist other therapies and cause lethal re-growth of cancer after surgery, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in the Sept. 18 edition of the Journal of the National Cancer Institute.